![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Regions :: North America Bio/pharma Outsourcing: Strategic Initiative, or Just Passing Off Low-end Jobs?7:54 AM MDT | July 28, 2010 | Eric S. Langer Managing Partner, BioPlan Associates (Rockville, MD) The Shift to Strategic Outsourcing Most companies today recognize the necessity to use their internal resources more efficiently. Outsourcing as a tool has been proven to permit greater focus on core competencies. In biopharmaceutical manufacturing, outsourcing complex activities can offer advantages beyond just cost effectiveness. However, even as outsourcing increases, the activities being outsourced, according to our most recent industry study, appear to be advancing more slowly. Our recently released... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|